close 73% dei conti retail perde denaro a causa delle negoziazioni in CFD con questo fornitore. Gli investimenti comportano rischi e non sono adatti a tutti gli investitori. I CFD sono strumenti complessi e comportano un alto rischio di perdere denaro rapidamente a causa della leva finanziaria. 73% dei conti degli investitori al dettaglio perde denaro quando fa trading di CFD con questo fornitore. Dovresti prendere in considerazione se comprendi come funzionano i CFD e se puoi permetterti di correre il rischio elevato di perdere i tuoi soldi.
Change languageItaliano
Dashboard

JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

JNJ

233.01

+1.03%↑

ISRG

478.71

-3.54%↓

ABT

108.96

-0.46%↓

RDY

13.8

+1.55%↑

NEOG

10.27

+0.39%↑

Home・Elenco Azioni・Matinas BioPharma Holdings Inc
Search

Matinas BioPharma Holdings Inc

Chiusa

0.58 -3.33

Aggiornamento del prezzo 3 feb 2026, 20:55 UTC

AcquistaVendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

0.58

Massimo

0.61

Dividendi

By Dow Jones

Utili prossimi

13 apr 2026

Matinas BioPharma Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 feb 2026, 23:52 UTC

Acquisizioni, Fusioni, Takeovers

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

DJ

LeggI

2 feb 2026, 23:52 UTC

Acquisizioni, Fusioni, Takeovers

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

DJ

LeggI

2 feb 2026, 23:48 UTC

Discorsi di Mercato

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

DJ

LeggI

2 feb 2026, 23:38 UTC

Discorsi di Mercato

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

DJ

LeggI

2 feb 2026, 23:28 UTC

Discorsi di Mercato

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

DJ

LeggI

2 feb 2026, 23:23 UTC

Utili

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

DJ

LeggI

2 feb 2026, 22:57 UTC

Utili

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

DJ

LeggI

2 feb 2026, 22:22 UTC

Acquisizioni, Fusioni, Takeovers

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

DJ

LeggI

2 feb 2026, 22:08 UTC

Discorsi di Mercato

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

DJ

LeggI

2 feb 2026, 21:51 UTC

Utili

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

DJ

LeggI

2 feb 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

DJ

LeggI

2 feb 2026, 21:49 UTC

Utili

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

DJ

LeggI

2 feb 2026, 21:39 UTC

Utili

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

DJ

LeggI

2 feb 2026, 21:36 UTC

Utili

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

DJ

LeggI

2 feb 2026, 21:34 UTC

Utili

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

DJ

LeggI

2 feb 2026, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

DJ

LeggI

2 feb 2026, 21:23 UTC

Utili

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

DJ

LeggI

2 feb 2026, 21:19 UTC

Utili

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

DJ

LeggI

2 feb 2026, 21:17 UTC

Utili

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

DJ

LeggI

2 feb 2026, 21:17 UTC

Utili

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

DJ

LeggI

2 feb 2026, 21:10 UTC

Utili

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

DJ

LeggI

2 feb 2026, 21:08 UTC

Utili

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

DJ

LeggI

2 feb 2026, 21:07 UTC

Utili

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

DJ

LeggI

2 feb 2026, 21:05 UTC

Utili

Palantir Technologies 4Q Net $608.7M >PLTR

DJ

LeggI

2 feb 2026, 21:05 UTC

Utili

Palantir Technologies 4Q Rev $1.41B >PLTR

DJ

LeggI

2 feb 2026, 21:05 UTC

Utili

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

DJ

LeggI

2 feb 2026, 21:05 UTC

Utili

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

DJ

LeggI

2 feb 2026, 21:05 UTC

Utili

Palantir Technologies 4Q Adj EPS 25c >PLTR

DJ

LeggI

2 feb 2026, 21:05 UTC

Utili

Palantir Technologies 4Q EPS 24c >PLTR

DJ

LeggI

2 feb 2026, 20:40 UTC

Discorsi di Mercato

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

DJ

LeggI

Confronto tra pari

Modifica del prezzo

Matinas BioPharma Holdings Inc Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

0

Acquista

0

Mantieni

0

Vendi

Basato sugli analisti di 0 che hanno fornito valutazioni azionarie a Matinas BioPharma Holdings Inc - Dist negli ultimi 3 mesi.

Notizie finanziarie

$

Altri titoli del settore

JNJ

Johnson and Johnson

233.01

↑ +1.03%

ISRG

Intuitive Surgical Inc

478.71

↓-3.54%

ABT

Abbott Laboratories

108.96

↓-0.46%

RDY

Dr Reddy's Laboratories Ltd-ADR

13.8

↑ +1.55%

NEOG

Neogen Corp

10.27

↑ +0.39%
help-icon Live chat